CANCER AND LEUKEMIA GROUP B
CANCER AND LEUKEMIA GROUP B
批准号:
3555902
负责人:
RICHARD T SILVER
金额:
$15.07万
依托单位国家:
美国
项目类别:
财政年份:
1979
资助国家:
美国
项目状态:
已结题
起止时间:
1979-04-01 至 1988-03-31
关键词:
6 thioguanine 6 thiopurine Hodgkin's disease anticoagulants asparaginase blood proteins cancer information system cancer rehabilitation mental health service carmustine central nervous system neoplasms cooperative study cyclophosphamide cytosine arabinoside dacarbazine data collection methodology /evaluation daunorubicin drug metabolism enzyme therapy fluorouracil human subject human therapy evaluation lymphocytic leukemia lymphoma melphalan methotrexate multiple myeloma myelogenous leukemia neoplasm /cancer chemotherapy neoplasm /cancer immunotherapy neoplasm /cancer radiation therapy neoplasm /cancer remission /regression neoplasm /cancer surgery nephroblastoma neuroblastoma oncology nursing pediatric neoplasm /cancer prednisone radiation therapy dosage reticuloendotheliosis vincristine
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This is an application for continuing research in clinical cancer as a
member of CALGB. The New York Hospital-Cornell Medical Center together
with its associated institutions, North Shore University Hospital and the
Firestone Radiation Center at Memorial Hospital, remains a major
contributor to the scientific, clinical and administrative activities of
CALGB. These are reflected in our participation in the scientific affairs
and programs of CALGB. Leadership activities are reflected in our
administrative and scientific contributions to CALGB, and in our pilot and
phase II programs and in our publications.
Our aims are to participate in a cooperative approach in the design and
conduct of therapeutic trials in cancer. In this context, we will (1)
determine the effect, extent and duration of remission and other responses
to treatment of the diseases currently of concern to CALGB, (2) study the
natural history and some of the biologic agents of the diseases
investigated by CALGB as modified by various experimental therapeutic
regimens, (3) promote the best possible treatment of these disorders, (4)
participate in pilot phase II and multidisciplinary trials of CALGB, (5)
continue a high level of patient accrual and continue to improve data
collection, (6) continue our vigorous participation in Group activities as
it pertains to Group science and Group administration with particular
reference to change in the Group's orientation and resources in the last
two years.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
STEM CELL RESCUE AFTER BONE MARROW CURETTAGE FOR TREATMENT OF AMM
-
批准号:6263945
-
项目类别:
-
资助金额:$7.95万
-
财政年份:1998
-
负责人:RICHARD T SILVER
-
依托单位:
131I-LYM-1 AT A DOSE OF 80MCI/M2 IN THE TREATMENT OF REFRACTORY B-CELL LYMPHOMA
-
批准号:6275226
-
项目类别:
-
资助金额:$5.51万
-
财政年份:1997
-
负责人:RICHARD T SILVER
-
依托单位:
131I-LYM-1 AT A DOSE OF 80MCI/M2 IN THE TREATMENT OF REFRACTORY B-CELL LYMPHOMA
-
批准号:6245107
-
项目类别:
-
资助金额:$5.36万
-
财政年份:1997
-
负责人:RICHARD T SILVER
-
依托单位:
CANCER AND LEUKEMIA GROUP B
-
批准号:3555904
-
项目类别:
-
资助金额:$19.8万
-
财政年份:1979
-
负责人:RICHARD T SILVER
-
依托单位:
CANCER AND LEUKEMIA GROUP B
-
批准号:3555903
-
项目类别:
-
资助金额:$20.86万
-
财政年份:1979
-
负责人:RICHARD T SILVER
-
依托单位:
CANCER AND LEUKEMIA GROUP B
-
批准号:3555900
-
项目类别:
-
资助金额:$14.3万
-
财政年份:1979
-
负责人:RICHARD T SILVER
-
依托单位:
CANCER AND LEUKEMIA GROUP B
-
批准号:3555901
-
项目类别:
-
资助金额:$13.22万
-
财政年份:1979
-
负责人:RICHARD T SILVER
-
依托单位:
CANCER AND LEUKEMIA GROUP B
-
批准号:3555905
-
项目类别:
-
资助金额:$21.48万
-
财政年份:1979
-
负责人:RICHARD T SILVER
-
依托单位:
CANCER AND LEUKEMIA GROUP B
-
批准号:3555906
-
项目类别:
-
资助金额:$22.51万
-
财政年份:1979
-
负责人:RICHARD T SILVER
-
依托单位:
CANCER AND LEUKEMIA GROUP B
-
批准号:3555898
-
项目类别:
-
资助金额:$19.25万
-
财政年份:1979
-
负责人:RICHARD T SILVER
-
依托单位:
131I-LYM-1 AT A DOSE OF 80MCI/M2 IN THE TREATMENT OF REFRACTORY B-CELL LYMPHOMA
-
批准号:5218014
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:RICHARD T SILVER
-
依托单位:--
131I-LYM-1 AT A DOSE OF 80MCI/M2 IN THE TREATMENT OF REFRACTORY B-CELL LYMPHOMA
-
批准号:6113991
-
项目类别:
-
资助金额:$5.82万
-
财政年份:--
-
负责人:RICHARD T SILVER
-
依托单位:
海外基金